Newer risk markers and surrogate endpoints in atherosclerosis management
- PMID: 11501598
- PMCID: PMC6655004
- DOI: 10.1002/clc.4960241504
Newer risk markers and surrogate endpoints in atherosclerosis management
Abstract
Risk markers that allow improved and individualized assessment of atherosclerotic disease risk and response to treatment are needed. Current candidate markers include cell adhesion molecules, such as intercellular adhesion molecule-1 and E-selectin, and inflammatory markers, such as C-reactive protein; advances in genomics and proteomics will suggest additional candidate markers. Noninvasive imaging procedures such as electron-beam computed tomography and magnetic resonance imaging also show considerable promise for monitoring disease status and response to treatment, and ultimately could provide surrogate endpoints for clinical trials of therapeutic interventions.
Similar articles
-
Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease.Int J Cardiol. 2006 Jan 13;106(2):183-90. doi: 10.1016/j.ijcard.2005.01.042. Int J Cardiol. 2006. PMID: 16321690
-
Levels of soluble E-selectin and ICAM-1 in the coronary circulation of patients with stable coronary artery disease: association with the severity of coronary atherosclerosis.Jpn Heart J. 2002 Mar;43(2):93-101. doi: 10.1536/jhj.43.93. Jpn Heart J. 2002. PMID: 12025910
-
Cytokines and soluble cell adhesion molecules. Possible markers of inflammatory response in atherosclerosis.Ann N Y Acad Sci. 2000 May;902:320-2. doi: 10.1111/j.1749-6632.2000.tb06331.x. Ann N Y Acad Sci. 2000. PMID: 10865856 No abstract available.
-
Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction.Intern Med J. 2003 Sep-Oct;33(9-10):450-62. doi: 10.1046/j.1445-5994.2003.00379.x. Intern Med J. 2003. PMID: 14511199 Review.
-
Laboratory surrogates for anti-atherosclerotic drug development.Am J Cardiol. 2001 Feb 16;87(4A):21A-26A. doi: 10.1016/s0002-9149(01)01421-7. Am J Cardiol. 2001. PMID: 11243601 Review.
Cited by
-
Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea.Sleep Breath. 2009 Nov;13(4):391-5. doi: 10.1007/s11325-009-0259-1. Epub 2009 May 5. Sleep Breath. 2009. PMID: 19415358
-
Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascades.Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12077-82. doi: 10.1073/pnas.0504526102. Epub 2005 Aug 16. Proc Natl Acad Sci U S A. 2005. PMID: 16105945 Free PMC article.
References
-
- Springer TA : Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995; 57: 827–872 - PubMed
-
- Hwang S‐J, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr. Boerwinkle E., Circulating adhesion molecules VCAM‐1, ICAM‐1, and E‐selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997; 96: 4219–4225 - PubMed
-
- Ridker PM, Hennekens CH, Roitman‐Johnson B., Stampfer MJ, Allen J., Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88–92 - PubMed
-
- Abe Y., El‐Masri B., Kimball KT, Pownall H., Reilly CF, Osmundsen K., Smith CW, Ballantyne CM, Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vase Biol 1998; 18: 723–731 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials